Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Linear Combinations of Multiple Outcome Measures to Improve the Power of Efficacy Analysis ---Application to Clinical Trials on Early Stage Alzheimer Disease.

Xiong C, Luo J, Morris JC, Bateman R.

Biostat Epidemiol. 2017;1(1):36-58. doi: 10.1080/24709360.2017.1331821. Epub 2017 Jun 2.

2.

Alzheimer disease prevention: New optimism.

Filley CM.

Neurol Clin Pract. 2015 Jun;5(3):193-200. doi: 10.1212/CPJ.0000000000000108.

3.
4.

Of Energy and Entropy: The Ineluctable Impact of Aging in Old Age Dementia.

Boccardi V, Comanducci C, Baroni M, Mecocci P.

Int J Mol Sci. 2017 Dec 9;18(12). pii: E2672. doi: 10.3390/ijms18122672. Review.

5.

Alzheimer's Disease: Past, Present, and Future.

Bondi MW, Edmonds EC, Salmon DP.

J Int Neuropsychol Soc. 2017 Oct;23(9-10):818-831. doi: 10.1017/S135561771700100X.

6.

Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening.

Kumar R, Kumar A, Långström B, Darreh-Shori T.

Sci Rep. 2017 Nov 24;7(1):16287. doi: 10.1038/s41598-017-16033-w.

7.

Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease.

Yang SY, Chiu MJ, Chen TF, Horng HE.

Neurol Ther. 2017 Jul;6(Suppl 1):37-56. doi: 10.1007/s40120-017-0075-7. Epub 2017 Jul 21. Review.

8.

Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases.

Cruz-Haces M, Tang J, Acosta G, Fernandez J, Shi R.

Transl Neurodegener. 2017 Jul 11;6:20. doi: 10.1186/s40035-017-0088-2. eCollection 2017. Review.

9.

Alzheimer Disease: Scientific Breakthroughs and Translational Challenges.

Caselli RJ, Beach TG, Knopman DS, Graff-Radford NR.

Mayo Clin Proc. 2017 Jun;92(6):978-994. doi: 10.1016/j.mayocp.2017.02.011. Review.

PMID:
28578785
10.

Frontotemporal Dementia.

Olney NT, Spina S, Miller BL.

Neurol Clin. 2017 May;35(2):339-374. doi: 10.1016/j.ncl.2017.01.008. Review.

PMID:
28410663
11.

White matter and cognition: making the connection.

Filley CM, Fields RD.

J Neurophysiol. 2016 Nov 1;116(5):2093-2104. doi: 10.1152/jn.00221.2016. Epub 2016 Aug 10. Review.

12.

Prediction of population with Alzheimer's disease in the European Union using a system dynamics model.

Tomaskova H, Kuhnova J, Cimler R, Dolezal O, Kuca K.

Neuropsychiatr Dis Treat. 2016 Jun 30;12:1589-98. doi: 10.2147/NDT.S107969. eCollection 2016.

13.

Perception of Alzheimer Disease in Iranian Traditional Medicine.

Saifadini R, Tajadini H, Choopani R, Mehrabani M, Kamalinegad M, Haghdoost A.

Iran Red Crescent Med J. 2016 Mar 1;18(3):e22054. doi: 10.5812/ircmj.22054. eCollection 2016 Mar. Review.

14.

Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study.

Xiong C, Jasielec MS, Weng H, Fagan AM, Benzinger TL, Head D, Hassenstab J, Grant E, Sutphen CL, Buckles V, Moulder KL, Morris JC.

Neurology. 2016 Apr 19;86(16):1499-506. doi: 10.1212/WNL.0000000000002593. Epub 2016 Mar 23.

15.

A mechanism for ultrasound/light-induced biostimulation.

Sommer AP.

Ann Transl Med. 2015 Nov;3(19):291. doi: 10.3978/j.issn.2305-5839.2015.09.18. No abstract available.

16.

Bivariate correlation coefficients in family-type clustered studies.

Luo J, D'Angela G, Gao F, Ding J, Xiong C.

Biom J. 2015 Nov;57(6):1084-109. doi: 10.1002/bimj.201400131. Epub 2015 Sep 11.

17.

Role of indigenous herbs in the management of Alzheimer's disease.

Nishteswar K, Joshi H, Karra RD.

Anc Sci Life. 2014 Jul-Sep;34(1):3-7. doi: 10.4103/0257-7941.150763. Review.

18.

Subsets of a large cognitive battery better power clinical trials on early stage Alzheimer's disease.

Xiong C, Weng H, Bennett DA, Boyle PA, Shah RC, Fague S, Hall CB, Lipton RB, Morris JC.

Neuroepidemiology. 2014;43(2):131-9. doi: 10.1159/000365733. Epub 2014 Nov 5.

19.

Redesigning systems of care for older adults with Alzheimer's disease.

Callahan CM, Sachs GA, Lamantia MA, Unroe KT, Arling G, Boustani MA.

Health Aff (Millwood). 2014 Apr;33(4):626-32. doi: 10.1377/hlthaff.2013.1260. Review.

20.

Combining Multiple Markers to Improve the Longitudinal Rate of Progression-Application to Clinical Trials on the Early Stage of Alzheimer's Disease.

Xiong C, van Belle G, Chen K, Tian L, Luo J, Gao F, Yan Y, Chen L, Morris JC, Crane P.

Stat Biopharm Res. 2013 Jan 1;5(1). doi: 10.1080/19466315.2012.756662.

Supplemental Content

Support Center